What type of study is this?

This is a Animal Study study (also classified as: Human Clinical Trial).

Research advances in mesenchymal stem cells and related therapies for rotator cuff tendon-to-bone healing

View Full Paper

Ask AI

Bookmark

Authors

Current therapies show reduced retear rates in rotator cuff injuries, suggesting MSCs may enhance tendon-to-bone healing.

Clinical studies demonstrate reduced retear rates with mesenchymal stem cell therapies, highlighting their potential effectiveness.
Animal models show inconsistent outcomes, influenced by factors like cell source and delivery methods, indicating a need for optimization.
Current approaches include direct MSC implantation and MSC-laden scaffolds, showcasing diverse strategies for better healing.
Emerging focus on MSC secretome, particularly exosomes, suggests new avenues for inflammation modulation and tissue repair.

Song et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark